These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2190366)

  • 1. Humoral immune response following extracorporeal immunoadsorption therapy of patients with hypercholesterolemia.
    Gordon BR; Sloan BJ; Parker TS; Saal SD; Levine DM; Rubin AL
    Transfusion; 1990 May; 30(4):327-32. PubMed ID: 2190366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the long-term efficacy and selectivity of immunoadsorption columns for low density lipoprotein apheresis.
    Jovin IS; Taborski U; Müller-Berghaus G
    ASAIO J; 2000; 46(3):298-300. PubMed ID: 10826740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies.
    Richter WO; Jacob BG; Ritter MM; Sühler K; Vierneisel K; Schwandt P
    Metabolism; 1993 Jul; 42(7):888-94. PubMed ID: 8345799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of immunosorbents for apoB-containing lipoproteins apheresis.
    Pokrovsky SN; Sussekov AV; Adamova IY; Afanasieva OI; Benevolenskaya GF; Konovalov GA; Kukharchuk VV
    Artif Organs; 1995 Jun; 19(6):500-5. PubMed ID: 8526788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporal low-density lipoprotein elimination by immunoadsorption.
    Ritter MM; Parhofer KG
    Ther Apher Dial; 2003 Jun; 7(3):370-2. PubMed ID: 12924615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of low density lipoprotein-apheresis for the therapy of severe hyperlipidemia.
    Gordon BR; Saal SD
    Curr Opin Lipidol; 1996 Dec; 7(6):381-4. PubMed ID: 9117142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
    Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement profile and activation mechanisms by different LDL apheresis systems.
    Hovland A; Hardersen R; Nielsen EW; Enebakk T; Christiansen D; Ludviksen JK; Mollnes TE; Lappegård KT
    Acta Biomater; 2012 Jul; 8(6):2288-96. PubMed ID: 22373816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.
    Bosch T; Schmidt B; Kleophas W; Otto V; Samtleben W
    Artif Organs; 1997 Oct; 21(10):1060-5. PubMed ID: 9335362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of low-density lipoproteins in patients by extracorporeal immunoadsorption.
    Saal SD; Parker TS; Gordon BR; Studebaker J; Hudgins L; Ahrens EH; Rubin AL
    Am J Med; 1986 Apr; 80(4):583-9. PubMed ID: 3515930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns.
    Gandjini H; Gambert P; Athias A; Mousson C; Rifle G; Lallemant C
    Transfus Sci; 1994 Sep; 15(3):289-97. PubMed ID: 10155547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis.
    Uauy R; Zwiener RJ; Phillips MJ; Petruska ML; Bilheimer DW
    J Pediatr; 1992 Jun; 120(6):892-8. PubMed ID: 1593349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia.
    Bräutigam R; Bräutigam C; Lorenz R; Richter WO; Engelmann B
    Atherosclerosis; 1997 May; 131(1):97-106. PubMed ID: 9180250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma.
    Stoffel W; Demant T
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):611-5. PubMed ID: 7017720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice.
    Masin V; Blaha M; Stransky P; Blaha V; Cermanova M; Maly R; Zajic J
    Transfus Apher Sci; 2007 Feb; 36(1):39-45. PubMed ID: 17292673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP).
    Lees RS; Holmes NN; Stadler RW; Ibrahim SF; Lees AM
    J Clin Apher; 1996; 11(3):132-7. PubMed ID: 8915817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).
    Waldmann E; Parhofer KG
    Pathology; 2019 Feb; 51(2):227-232. PubMed ID: 30611543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.